77 related articles for article (PubMed ID: 17931866)
1. Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists.
Zhao Z; Araldi GL; Xiao Y; Reddy AP; Liao Y; Karra S; Brugger N; Fischer D; Palmer E
Bioorg Med Chem Lett; 2007 Dec; 17(23):6572-5. PubMed ID: 17931866
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists.
Xiao Y; Araldi GL; Zhao Z; Brugger N; Karra S; Fischer D; Palmer E
Bioorg Med Chem Lett; 2007 Aug; 17(15):4323-7. PubMed ID: 17531488
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a gamma-lactam as a highly selective EP2 and EP4 receptor agonist.
Xiao Y; Araldi GL; Zhao Z; Reddy A; Karra S; Brugger N; Fischer D; Palmer E; Bao B; McKenna SD
Bioorg Med Chem Lett; 2008 Jan; 18(2):821-4. PubMed ID: 18039575
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma.
Chung KF
Sci STKE; 2005 Sep; 2005(303):pe47. PubMed ID: 16189372
[TBL] [Abstract][Full Text] [Related]
5. Effects of prostanoid EP agonists on mouse intraocular pressure.
Saeki T; Ota T; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
[TBL] [Abstract][Full Text] [Related]
6. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.
Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N
Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo.
Nomi T; Sho M; Akahori T; Kanehiro H; Nakajima Y
Transplant Proc; 2006 Dec; 38(10):3209-10. PubMed ID: 17175225
[TBL] [Abstract][Full Text] [Related]
8. Functional pharmacology of human prostanoid EP2 and EP4 receptors.
Wilson RJ; Rhodes SA; Wood RL; Shield VJ; Noel LS; Gray DW; Giles H
Eur J Pharmacol; 2004 Oct; 501(1-3):49-58. PubMed ID: 15464062
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a potent and selective agonist of the prostaglandin EP4 receptor.
Billot X; Chateauneuf A; Chauret N; Denis D; Greig G; Mathieu MC; Metters KM; Slipetz DM; Young RN
Bioorg Med Chem Lett; 2003 Mar; 13(6):1129-32. PubMed ID: 12643927
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors.
Hatazawa R; Tanigami M; Izumi N; Kamei K; Tanaka A; Takeuchi K
Inflammopharmacology; 2007 Oct; 15(5):214-7. PubMed ID: 17943254
[TBL] [Abstract][Full Text] [Related]
11. Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: impaired responsiveness in heterozygotes.
Zhan P; Alander C; Kaneko H; Pilbeam CC; Guan Y; Zhang Y; Breyer MD; Raisz LG
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):19-26. PubMed ID: 16303601
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 inhibits mineralization and enhances matrix metalloproteinase-13 in mature cementoblasts mainly via the EP4 pathway.
Oka H; Miyauchi M; Sakamoto K; Kitagawa M; Noguchi K; Somerman MJ; Takata T
Arch Oral Biol; 2008 Mar; 53(3):243-9. PubMed ID: 18045572
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of γ-lactam analogs of PGE₂ as EP4 and EP2/EP4 agonists.
Kambe T; Maruyama T; Nakai Y; Oida H; Maruyama T; Abe N; Nishiura A; Nakai H; Toda M
Bioorg Med Chem; 2012 Jun; 20(11):3502-22. PubMed ID: 22546206
[TBL] [Abstract][Full Text] [Related]
14. Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives.
Tani K; Naganawa A; Ishida A; Sagawa K; Harada H; Ogawa M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2002 Apr; 10(4):1093-106. PubMed ID: 11836120
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists.
Kambe T; Maruyama T; Nakai Y; Yoshida H; Oida H; Maruyama T; Abe N; Nishiura A; Nakai H; Toda M
Bioorg Med Chem; 2012 Apr; 20(7):2235-51. PubMed ID: 22386979
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E(2) suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E-prostanoid 2-mediated pathway in nasal polyps.
Okano M; Fujiwara T; Haruna T; Kariya S; Makihara S; Higaki T; Nishizaki K
J Allergy Clin Immunol; 2009 Apr; 123(4):868-74.e13. PubMed ID: 19254809
[TBL] [Abstract][Full Text] [Related]
17. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2.
Watanabe Y; Namba A; Honda K; Aida Y; Matsumura H; Shimizu O; Suzuki N; Tanabe N; Maeno M
Connect Tissue Res; 2009; 50(3):186-93. PubMed ID: 19444759
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation.
Zahner G; Schaper M; Panzer U; Kluger M; Stahl RA; Thaiss F; Schneider A
Biochem J; 2009 Aug; 422(3):563-70. PubMed ID: 19570035
[TBL] [Abstract][Full Text] [Related]
19. Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterus.
Terry KK; Lebel WS; Riccardi KA; Grasser WA; Thompson DD; Paralkar VM
Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):3-10. PubMed ID: 18036799
[TBL] [Abstract][Full Text] [Related]
20. Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.
Cameron KO; Lefker BA; Ke HZ; Li M; Zawistoski MP; Tjoa CM; Wright AS; DeNinno SL; Paralkar VM; Owen TA; Yu L; Thompson DD
Bioorg Med Chem Lett; 2009 Apr; 19(7):2075-8. PubMed ID: 19250823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
